Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Capital Expenditures (2020 - 2026)

Rani Therapeutics Holdings' Capital Expenditures history spans 7 years, with the latest figure at $15000.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 70.59% to $15000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $52000.0, a 82.72% decrease, with the full-year FY2025 number at $88000.0, down 67.16% from a year prior.
  • Capital Expenditures came in at $15000.0 for Q1 2026, down from $37000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $1.3 million in Q4 2022, with the low at -$1.0 million in Q4 2023.
  • Historically, Capital Expenditures has averaged $133866.7 across 5 years, with a median of $51000.0 in 2025.
  • Peak annual rise in Capital Expenditures hit 1011.51% in 2022, while the deepest fall reached 673.47% in 2022.
  • Year by year, Capital Expenditures stood at $1.3 million in 2022, then plummeted by 182.4% to -$1.0 million in 2023, then soared by 102.97% to $31000.0 in 2024, then grew by 19.35% to $37000.0 in 2025, then crashed by 59.46% to $15000.0 in 2026.
  • Business Quant data shows Capital Expenditures for RANI at $15000.0 in Q1 2026, $37000.0 in Q2 2025, and $51000.0 in Q1 2025.